Financials
- Market Capitalization 403.53 M
- Employee 45
- Founded 2019
- CEO N/A
- Website www.x4pharma.com
- Headquarter Delaware, United States
- FIGI BBG001J1CYH8
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
3.68
市销率
35.88
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3030 | RCKT Rocket Pharmaceuticals, Inc. - Common Stock | 3.72 USD | 0.00% | -1.59% | +18.85% | +13.76% | 408.36 M USD | ||
| 3031 | CMPX Compass Therapeutics, Inc. - Common Stock | 2.32 USD | -2.93% | -8.30% | +19.59% | -32.75% | 417.80 M USD | ||
| 3051 | LRMR Larimar Therapeutics, Inc. - Common Stock | 3.91 USD | +2.36% | -5.10% | +2.09% | +6.83% | 406.18 M USD | ||
| 3085 | ENTA Enanta Pharmaceuticals, Inc. - Common Stock | 13.46 USD | +0.98% | -5.81% | +5.98% | +54.71% | 392.03 M USD |